Bioasis is a Connecticut-based biopharmaceutical company that develops and commercializes therapies for the treatment of neurological and metabolic disorders.
Business Model:
Revenue: $36.7B
Employees: 10,001-999,999
Address: 157 Church Street
City: New Haven
State: CT
Zip: 06510
Country: US
Bioasis is a Connecticut-based biopharmaceutical company that develops and commercializes therapies for the treatment of neurological and metabolic disorders.
Contact Phone:
+12035337082
Contact Email:
Listed Exchange:
NYSE
IPO Date:
7/27/2007
Ticker Symbol:
BTI
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2022 | Private Placement | $200k | 2/2022 | Private Placement | $200k | 11/2019 | Debt | $619.9k | 12/2019 | Post-IPO Equity | $530k | 6/2021 | Post-IPO Debt | $2.4M |
The Lind Partners, LLC |
6/2021 | Post-IPO Debt | $0 |
The Lind Partners The Lind Partners |
1/2021 | Private Placement | $200k | 6/2021 | Post-IPO Debt | 1 | $8.1M |
The Lind Partners The Lind Partners |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|